ZA967626B - Lipid extract having anti-inflammatory activity. - Google Patents

Lipid extract having anti-inflammatory activity.

Info

Publication number
ZA967626B
ZA967626B ZA9607626A ZA967626A ZA967626B ZA 967626 B ZA967626 B ZA 967626B ZA 9607626 A ZA9607626 A ZA 9607626A ZA 967626 A ZA967626 A ZA 967626A ZA 967626 B ZA967626 B ZA 967626B
Authority
ZA
South Africa
Prior art keywords
pct
lipid extract
date
inflammatory activity
sec
Prior art date
Application number
ZA9607626A
Other languages
English (en)
Inventor
Theodore Macrides
Nicolette Kalafatis
Original Assignee
Broadbent J W Nominees Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Broadbent J W Nominees Pty Ltd filed Critical Broadbent J W Nominees Pty Ltd
Publication of ZA967626B publication Critical patent/ZA967626B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9607626A 1995-09-11 1996-09-10 Lipid extract having anti-inflammatory activity. ZA967626B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN5311A AUPN531195A0 (en) 1995-09-11 1995-09-11 Lipid extract having anti-inflamatory activity

Publications (1)

Publication Number Publication Date
ZA967626B true ZA967626B (en) 1997-09-03

Family

ID=3789640

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9607626A ZA967626B (en) 1995-09-11 1996-09-10 Lipid extract having anti-inflammatory activity.

Country Status (12)

Country Link
US (2) US6083536A (de)
EP (1) EP0850068B1 (de)
JP (1) JP4101876B2 (de)
AT (1) ATE293984T1 (de)
AU (1) AUPN531195A0 (de)
CA (1) CA2231803C (de)
DE (1) DE69634666T2 (de)
DK (1) DK0850068T3 (de)
ES (1) ES2241001T3 (de)
PT (1) PT850068E (de)
WO (1) WO1997009992A1 (de)
ZA (1) ZA967626B (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN531195A0 (en) * 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity
EP0986315A4 (de) * 1997-06-04 2001-05-02 Improvements Ltd Cellular Verfahren und vorrichtung zur auflösung des biologischen materials
SE9703085D0 (sv) * 1997-08-27 1997-08-27 Micro Active Protein In Sweden Anti-microbial composition
US6946144B1 (en) 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
US7220427B2 (en) 1998-07-08 2007-05-22 Oryxe Mixture for transdermal delivery of low and high molecular weight compounds
DE19838794A1 (de) * 1998-08-26 2000-03-09 Aristavet Veterinaerspezialita Zusammensetzung zur Behandlung von Osteoarthritis und zur nutritiven Behandlung des Gelenkknorpels
AUPP910699A0 (en) * 1999-03-10 1999-04-01 Pharmalink International Limited Inhibitor of lipoxygenase pathways
AU2005200953B2 (en) * 1999-03-22 2007-07-12 Mars, Incorporated Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals and method of manufacturing same
US6596303B1 (en) * 1999-03-22 2003-07-22 Mars Incorporated Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals
US20020018787A1 (en) * 1999-05-21 2002-02-14 Roger V. Kendall Methods and compositions for modulating immune response and for the treatment of inflammatory disease
JP2003504408A (ja) * 1999-07-21 2003-02-04 ボマック・ラボラトリーズ・リミテッド 炎症及び／又は退行性疾患に対処する組成物
ATE270558T1 (de) 1999-08-26 2004-07-15 Ganeden Biotech Inc Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
AUPR030800A0 (en) * 2000-09-22 2000-10-12 Pharmalink International Limited Immunomodulatory preparation
AU2001293477B2 (en) * 2000-09-22 2006-05-18 Pharmalink International Limited Immunomodulatory preparation
US7519546B2 (en) * 2001-04-30 2009-04-14 General Electric Company Maintaining synchronization of information published to multiple subscribers
DE60220415T2 (de) 2001-07-27 2008-02-14 Neptune Technologies & Bioressources Inc., Laval Flavonoide und mehrfach ungesättigte fettsäuren enthaltende natürliche phospholipide maritimen ursprungs sowie deren anwendungen
AUPS082102A0 (en) * 2002-03-01 2002-03-21 Women's And Children's Hospital Therapeutic properties of oils
AU2003222002A1 (en) * 2002-03-14 2003-09-29 Jackie H. Mcclung Pharmaceutically active compounds containing phosphorous defficient oil
DE20210182U1 (de) * 2002-07-01 2002-10-02 Bio-Innovation Development Ltd., Christchurch Wirkstoffzusammensetzung aus Bestandteilen der Grünlippenmuschel (perna canaliculus) und zusätzlichen Omega-3-Fettsäuren
MXPA05009894A (es) * 2003-03-14 2006-12-14 Foodscience Corp Metodos para el tratamiento de cancer usando componente(s) de perna canaliculus y extractos de perna canaliculus.
US7033998B2 (en) * 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
US7052715B2 (en) * 2003-04-11 2006-05-30 All Natural Fmg, Inc. Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
EP1716221B1 (de) * 2004-01-30 2008-11-05 Bionovate Limited Lösungsmittelextraktion von lipiden aus perna canaliculus
GB0411165D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Hyaluronic acid containing pharmaceutical or veterinary compounds
GB0411166D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Treatment for asthma and arthritis
US20060039992A1 (en) * 2004-06-02 2006-02-23 Miller Bruce A Jr Novel compositions and methods utilizing green-lipped mussel and fatty acids
WO2006052150A1 (en) * 2004-11-15 2006-05-18 University Of Otago Mussel extract composition with enhanced anti-inflammatory activity
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8431165B2 (en) * 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
NZ563125A (en) * 2005-06-03 2009-11-27 Mcfarlane Marketing Aust Pty L Lipid extract of mussels and method for preparation thereof
NZ547429A (en) * 2006-05-24 2009-09-25 Ind Res Ltd Extraction of highly unsaturated lipids with liquid dimethyl ether
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
WO2008012602A1 (en) 2006-07-25 2008-01-31 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of diclofenac with very fast skin penetration rate
CN101489985B (zh) 2006-07-18 2014-01-08 天津昕晨泰飞尔医药科技有限公司 具有快速皮肤穿透率的带正电荷的水溶性布洛芬前药
DK2049482T3 (en) 2006-08-08 2016-02-01 Techfields Biochem Co Ltd Positively charged, water-soluble prodrugs of aryl and heteroaryl acetic acids with very fast skin penetration rate
CN101506143B (zh) 2006-09-03 2013-06-05 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的对乙酰氨基酚及其相关化合物的前药
EP2623495B1 (de) 2006-09-03 2019-05-01 Techfields Biochem Co. Ltd Positiv geladene, wasserlösliche Prodrugs von Arylanthranilsäuren mit sehr schneller Hautpenetrationsrate
WO2008035756A1 (fr) * 2006-09-22 2008-03-27 Heimat Co., Ltd. Composition anti-angiogénique comportant un extrait ayant une activité anti-angiogénique et une lécithine
EP2084124B9 (de) * 2006-10-02 2015-07-01 Techfields Biochem Co. Ltd Positiv geladene wasserlösliche prodrugs von prostaglandinen und verwandten verbindungen mit sehr hohen hautpenetrationsraten
EP2084165B1 (de) 2006-10-11 2013-06-12 Techfields Biochem Co. Ltd Positiv geladene, wasserlösliche prodrugs von oxicamen und verwandten verbindungen mit sehr hoher hautpenetrationsrate
NZ552238A (en) * 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
WO2008146298A1 (en) * 2007-06-01 2008-12-04 Ganga Raju Gokaraju Use of aphanamixis polystacha extracts or fractions against 5 -lipoxygenase mediated diseases
KR20190091378A (ko) * 2007-06-04 2019-08-05 테크필즈 인크 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(ｎｓａｉａ) 약물전구체 및 이들의 새로운 의약적 용도
BRPI0822603A2 (pt) * 2008-04-28 2015-06-16 Vermont Italia Srl Formulação farmacêutica contendo palmitoil etanolamina e estearoil etanolamina.
KR20210123406A (ko) 2008-12-04 2021-10-13 충시 위 고투과력을 가진 조성물 및 이의 적용
JP5313064B2 (ja) * 2009-07-03 2013-10-09 株式会社ノエビア 中性脂肪蓄積促進剤、豊胸剤
KR102443057B1 (ko) 2012-01-18 2022-09-14 테크필즈 파마 코., 엘티디. 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물
JP6176655B2 (ja) * 2013-07-02 2017-08-09 御木本製薬株式会社 マトリックスメタロプロテアーゼ活性阻害剤、皮膚外用剤、老化防止用皮膚外用剤、シワ防止用皮膚外用剤、慢性関節リウマチ及び他の疾患の治療又は予防剤
US10568938B2 (en) * 2015-07-20 2020-02-25 Jiangyin Bengt I. Samuelsson Institute Of Life Science Co., Ltd. Mussel adhesive protein product and applications thereof in suppression of skin inflammations
BR112018005315A2 (pt) 2015-09-17 2018-10-09 Jrx Biotechnology Inc abordagens para aprimorar hidratação ou umidificação de pele
CN110213971A (zh) * 2016-12-20 2019-09-06 三福有限公司 加工贝类的方法和所得的组合物
KR20200096593A (ko) * 2017-12-04 2020-08-12 림프로스트 테크놀로지스 에이에스 갑각류 어획물로부터 단백질 인지질 복합체를 제조하는 방법
LT3727404T (lt) 2017-12-22 2023-10-25 Pharmalink International Limited Kompozicijos, apimančios midijų lipidų ekstraktą ir krilių aliejų bei jų medicininis taikymas
CN115023140A (zh) 2020-01-21 2022-09-06 林贝尔有限公司 协同组合物
CN113041263B (zh) * 2021-03-15 2023-07-25 青岛大学 一种贻贝功能性脂质在制备治疗2型糖尿病产品中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965855D1 (en) 1978-09-25 1983-08-18 Farlane Stuart John Mc Pharmaceutical preparations containing a mollusc extract
US4801453A (en) * 1984-05-01 1989-01-31 James M. Broadbent Stabilized mussel extract
AU3156595A (en) * 1994-08-11 1996-03-07 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
AUPM740594A0 (en) 1994-08-11 1994-09-01 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
AUPN531195A0 (en) * 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity

Also Published As

Publication number Publication date
PT850068E (pt) 2005-08-31
ATE293984T1 (de) 2005-05-15
CA2231803A1 (en) 1997-03-20
EP0850068B1 (de) 2005-04-27
JPH11512400A (ja) 1999-10-26
US6346278B1 (en) 2002-02-12
ES2241001T3 (es) 2005-10-16
CA2231803C (en) 2004-11-23
DE69634666T2 (de) 2006-04-27
US6083536A (en) 2000-07-04
DE69634666D1 (de) 2005-06-02
EP0850068A1 (de) 1998-07-01
WO1997009992A1 (en) 1997-03-20
EP0850068A4 (de) 2000-09-13
DK0850068T3 (da) 2005-08-15
AUPN531195A0 (en) 1995-10-05
JP4101876B2 (ja) 2008-06-18

Similar Documents

Publication Publication Date Title
ZA967626B (en) Lipid extract having anti-inflammatory activity.
AU3402295A (en) Methods and means for drug administration
GB9519661D0 (en) Fatty acid treatment
DK0880350T3 (da) Behandling af dissemineret sklerose
GR3036745T3 (en) New pharmaceutical preparation for pain management
GEP20022783B (en) Method of Preventing and Delaying Onset of Alzheimer's Disease and Composition Therefor
PT920323E (pt) Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica
GB9408775D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
AU6739787A (en) Colony stimulating factor for the treatment of aids-type diseases
PT998287E (pt) Utilizacao de levobupivacaina
AU3092397A (en) Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases
AU1458495A (en) Application of riluzole in the treatment of mitochondrial diseases
AU691336B2 (en) Use of 2,4-diamino pyrimidine 3-oxide or a salt thereof for treating collagen maturation and structuring disorders
AU3401093A (en) Therapeutic agent for threatened abortion
NZ299257A (en) Treating purulent material (eg pulmonary disease) accumulation in patients using deamidated DNase
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
ES2110104T3 (es) Procedimiento para la administracion de soluciones de factor de estimulacion de las colonias de granulocitos.
AU5870298A (en) 1,4-dihydropyridin derivatives and their use in therapy
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору
ECSP951424A (es) Procedimiento para la administracion de azitromicina
CA2287903A1 (en) Method for treating medical conditions using a microprocessor-based video game